NCT05813418View on ClinicalTrials.gov

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 2, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
ImmunotherapyImmune Checkpoint InhibitorsImmune-related Adverse EventPredictive Biomarkers
Interventions
BIOLOGICAL

blood retriewal

blood retriewal for cytokine concentration measurement

Trial Locations (1)

80054

RECRUITING

CHU Amiens Picardie, Amiens

All Listed Sponsors
collaborator

Central Hospital Saint Quentin

OTHER_GOV

lead

Centre Hospitalier Universitaire, Amiens

OTHER